| __timestamp | Amicus Therapeutics, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 20140000 |
| Thursday, January 1, 2015 | 47269000 | 37173000 |
| Friday, January 1, 2016 | 71151000 | 48616000 |
| Sunday, January 1, 2017 | 88671000 | 108488000 |
| Monday, January 1, 2018 | 127200000 | 244622000 |
| Tuesday, January 1, 2019 | 169861000 | 287000000 |
| Wednesday, January 1, 2020 | 156407000 | 354000000 |
| Friday, January 1, 2021 | 192710000 | 186000000 |
| Saturday, January 1, 2022 | 213041000 | 151000000 |
| Sunday, January 1, 2023 | 275270000 | 232600000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, strategic financial management is crucial. Over the past decade, Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc. have demonstrated distinct patterns in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amicus Therapeutics saw a staggering 1,230% increase in SG&A spending, peaking at $275 million in 2023. In contrast, Ionis Pharmaceuticals experienced a more moderate 1,055% rise, with a high of $354 million in 2020 before a decline to $232 million in 2023. This divergence highlights differing strategic priorities: while Amicus has consistently ramped up its spending, Ionis appears to be optimizing its expenditures. These trends offer a window into each company's operational focus and market strategy, providing valuable insights for investors and industry analysts alike.
Eli Lilly and Company vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Alnylam Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Sarepta Therapeutics, Inc. and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.